1 result
  • HeartMate PHP SHIELD II

    A multicenter, prospective, randomized, open-label trial indicated for use during high-risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction.

    Type: Device trial

    Principal Investigator: Marc Cohen, MD

    Trial is not open for enrollment

    For inquiries, call (973) 926-8451
    • Newark Beth Israel Medical Center